Segment Data

9 Months Ended

Jun. 30, 2016

Segment Reporting [Abstract]

Segment Data

Segment Data

The Company's organizational structure is based upon two principal business segments: BD Medical (“Medical”) and BD Life Sciences (“Life Sciences”). These segments are strategic businesses that are managed separately because each one develops, manufactures and markets distinct products and services. The Company evaluates performance of its business segments and allocates resources to them primarily based upon operating income. Segment operating income represents revenues reduced by product costs and operating expenses.

Financial information for the Company’s segments was as follows:

	Three Months Ended June 30,						Nine Months Ended June 30,
(Millions of dollars)	2016			2015			2016			2015
Revenues (A)
Medical	$	2,235		$	2,199		$	6,420		$	4,377
Life Sciences	963			921			2,832			2,845
Total Revenues	$	3,198		$	3,120		$	9,252		$	7,222
Income Before Income Taxes
Medical	$	571		$	483		$	1,549		$	1,115
Life Sciences	200			197			604			610
Total Segment Operating Income	771			680			2,152			1,725
Acquisitions and other restructurings	(96		)	(108		)	(321		)	(244		)
Net interest expense	(92		)	(103		)	(279		)	(252		)
Other unallocated items (B)	(160		)	(430		)	(488		)	(680		)
Income Before Income Taxes	$	422		$	39		$	1,065		$	549

(A) Intersegment revenues are not material.

(B) Primarily comprised of foreign exchange, corporate expenses, and share-based compensation expense. The amounts in the three and nine-month periods of fiscal year 2015 also included a fair value step-up adjustment of $281 million recorded relative to CareFusion’s inventory on the acquisition date.

Revenues by geographic areas were as follows:

	Three Months Ended June 30,				Nine Months Ended June 30,
(Millions of dollars)	2016		2015		2016		2015
Revenues
United States	$	1,735	$	1,693	$	5,145	$	3,437
International	1,463		1,427		4,107		3,785
Total Revenues	$	3,198	$	3,120	$	9,252	$	7,222